Quantellect · Analysts · Analyst Profile
Analyst rating accuracy & track record
Michael DiFiore does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 ALTAltimmune Inc | Buy | $25.00 | Aug 2025 | −38.2% | Miss |
| ALTAltimmune Inc | Buy | $25.00 | Aug 2025 | −38.2% | Miss |
 SKYESkye Bioscience, Inc. Common Stock | Buy | $10.00 | Aug 2025 | −112.3% | Miss |
| SKYESkye Bioscience, Inc. Common Stock | Buy | $10.00 | Aug 2025 | −112.3% | Miss |
Prev1Next
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.